Cytek Biosciences, Inc. (CTKB) Misses Q4 EPS by 32c, provides guidance Feb 26, 2026 04:10PM
Cytek Biosciences reports preliminary Q4 revenue of $62 million Jan 12, 2026 05:16AM
Cytek Biosciences, Inc. (CTKB) Misses Q3 EPS by 1c, Beats on Revenue Nov 5, 2025 04:42PM
Cytek Biosciences, Inc. (CTKB) Reports In-Line Q2 EPS ; Offers Guidance Aug 6, 2025 04:27PM
Piper Sandler: 'Opportunities to Buy Dislocated Stocks after Prints' Jul 25, 2025 12:02PM


May 9, 2025 05:39AM TD Cowen Downgrades Cytek Biosciences Inc (CTKB) to Hold
May 8, 2025 04:36PM Cytek Biosciences, Inc. (CTKB) Misses Q1 EPS by 7c, Misses on Revenue; Offers FY25 Revenue Guidance
Mar 18, 2025 05:14PM Cytek® Biosciences (CTKB) announces Cytek Muse Micro system
Feb 27, 2025 04:23PM Cytek Biosciences, Inc. (CTKB) reported revenue at $57.5 million
Jan 31, 2025 04:07AM Goldman Sachs Downgrades Cytek Biosciences Inc (CTKB) to Sell
Jan 15, 2025 08:04AM Cytek® Biosciences (CTKB) Reports Prelim FY24 Results
Dec 30, 2024 08:03AM Cytek® Biosciences (CTKB) Announces $50M Share Buyback
Nov 25, 2024 08:19AM Cytek Biosciences Inc (CTKB) PT Lowered to $8.25 at Piper Sandler
Nov 5, 2024 04:11PM Cytek Biosciences, Inc. (CTKB) Reports In-Line Q3 EPS ; Offers Guidance
Aug 21, 2024 05:00PM Cytek® Biosciences (CTKB) Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
Aug 6, 2024 04:24PM Cytek Biosciences, Inc. (CTKB) Misses Q2 EPS by 8c ; Offers Guidance